(Bloomberg) -- Philip Morris International Inc. is raising its bid for the U.K. asthma drug maker Vectura Group Plc to 165 pence apiece, the company announced on Sunday.
ADVERTISEMENT
The increased offer s Vectura’s shares at about GBP1.02 billion, according to an emailed statement.
ADVERTISEMENT
NOTE, from Aug 6: Carlyle Raises Offer for Vectura, Elbowing Out Philip Morris
©2021 Bloomberg L.P.